Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
AdvaMed, aforementioned, aggressive, aiding, aimed, alia, alongside, Alzheimer, Amphora, AMPREVENCE, Analgesia, antitrust, attendant, biopharmaceutical, birth, bitartrate, brain, capsule, certiorari, check, chlamydia, citing, citric, clause, cognitive, comfort, compact, contraceptive, CRL, database, debilitating, dementia, derecognition, disciplined, dissolution, dissolve, distributor, divestiture, draft, drafted, economy, eighteen, energy, engineering, entail, EVFM, evofem, evolution, explicit, feasible, feedback, fit, forthcoming, gel, gonorrhea, halt, imaging, imminent, implicit, impractical, inactive, inquest, intact, intraperiod, Italy, Leerink, lengthen, lessee, lessor, living, machine, MAMKangaroo, mechanism, mediate, memory, merger, mission, monoclonal, Multipurpose, newer, North, NYSE, obviating, older, operationally, outbreak, overstatement, Parliament, pathway, payroll, PCA, PHOENIX, phrase, pioneered, platform, potassium, pregnancy, preoperative, profound, progression, proportionate, prototyping, Quantifying, rata, rationale, RBC, reacquisition, recalculated, receptive, reinforce, reinterpreted, reproductive, residual, resigned, ROU, RTI, saleable, sequencing, sequestration, sexual, Sherman, shift, shortly, slower, solanezumab, South, Speedel, standalone, successor, sunset, surfaced, surgeon, SVB, theater, thereon, tie, Torreya, traceability, transferee, transposing, travel, turmoil, ultrasound, unconstitutional, undergo, understated, unguaranteed, uniform, unlawfully, unlock, unwilling, upside, urogenital, Vaginal, variance, widespread, wind, winding, workstation, worsen, Wuhan
Removed:
achieved, adhesion, alternate, analyst, ascertain, assisting, attracting, augment, bidder, bind, buy, capacity, cellular, chose, commensurate, comparison, complement, confidential, consummate, contesting, continual, continuously, contributory, declared, deliver, dropped, Elan, encountered, encouraging, entering, EPS, escalation, Eurodollar, factually, finalize, forma, gaining, Gazyva, hedged, Hoffman, incurrence, ineffective, innovate, integrating, involvement, judged, LaRoche, leading, LG, managerial, marketable, master, maximizing, obligor, opening, perspective, quickly, recording, recruit, remeasured, rent, resale, restructure, restructured, Roche, run, seventeen, speculative, stopped, strong, supportable, tenant, transact, unaffected, venture, worth
Filing tables
Filing exhibits
- 10-K Annual report
- 4.8 Description of Registrants Securities
- 10.66 Fifth Amendement to Lease Agreement
- 10.67 Severance Plan
- 10.68 Form of Restricted Stock Agreement
- 10.69 Form of Restricted Stock Agreement Amendment Acknowledgement
- 10.70 Form of Stock Option Agreement
- 10.71 Form of Stock Option Agreement Amendment Acknowledgement
- 10.72 Form of Stock Option Grant Notice Supplement
- 10.73 Form of Nonstatutory Inducment Stock Option Agreement
- 10.74 Form of Nonstatutory Inducment Stock Option Agreement Notice Suppplement
- 10.75 Form of Inducement Restricted Stock Agreement
- 10.76 Wind Down Retention Plan
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- Download Excel data file
- View Excel data file
Related press release
Associated PDLI transcripts
PDLI similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-36708, 333-122760, 333-123958, 333-128644, 333-211970 and 333-231870) and on Form S-8 (No. 333-87957, 333-68314, 333-104170, 333-125906, 333-145262, 333-220370, 333-220435 and 333-225534) of PDL Biopharma, Inc., of our report dated March 11, 2020 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Francisco, California
March 11, 2020